Glycogen Storage Disease Type V (McArdle's Disease) Summary

Networked: 300 relevant articles (17 outcomes, 32 trials/studies) for this Disease

Key Drugs and Agents for Glycogen Storage Disease Type V

1. Glucagon (Glukagon) : 3 outcomes 1 study in 4 results : FDA 4
   
2. Myophosphorylase deficiency : 2 outcomes 4 studies in 74 results : IBA
   
3. Glucose (Dextrose) : 2 outcomes 1 study in 16 results : FDA 175 Generic
   
4. Adenosine Triphosphate (ATP) : 2 outcomes 1 study in 10 results : IBA
   
5. Vitamin B 6 : 2 outcomes 1 study in 3 results : IBA
   
6. Creatine : 1 outcome 5 studies in 9 results : IBA
   
7. Muscle Form Glycogen Phosphorylase (Myophosphorylase) : 1 outcome 1 study in 64 results : IBA
   
8. Ribose (D-Ribose) : 1 outcome 1 study in 3 results : IBA
   
9. Verapamil (Calan) : 1 outcome 1 study in 2 results : FDA 64 Generic
   
10. Ramipril (Altace) : 1 outcome 1 study in 1 result : FDA 15 Generic
    

Diseases Related to Glycogen Storage Disease Type V

1. Glycogen Storage Disease (Glycogenosis)
2. Glycogen Storage Disease Type VII (Tarui's Disease)
3. Mitochondrial Myopathies (Mitochondrial Myopathy)
4. Pain (Aches)
5. Muscular Diseases (Myopathy)

Key Therapies for Glycogen Storage Disease Type V

1. Ketogenic Diet : 1 outcome 1 study in 2 results
   
2. Activities of Daily Living (ADL) : 2 studies in 3 results
   
3. Anesthesia : 4 results
   
4. Cesarean Section (Caesarean Section) : 3 results
   
5. Microelectrodes : 2 results